Savant Capital’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
32,957
+1,281
+4% +$46.1K ﹤0.01% 702
2026
Q1
$777K Buy
31,676
+1,616
+5% +$38.3K ﹤0.01% 706
2025
Q4
$746K Sell
30,060
-618
-2% -$16.4K ﹤0.01% 672
2025
Q3
$870K Buy
30,678
+643
+2% +$17.4K 0.01% 619
2025
Q2
$747K Buy
+30,035
New +$846K 0.01% 617

Other funds holding ASTH

Savant Capital's ASTH Position: Q2 2026 in Review

Savant Capital increased its Astrana Health (ASTH) stake by 4% in Q2 2026, buying an estimated $46.1K and bringing the position to 32,957 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Savant Capital first reported a position in ASTH in Q2 2025 and has held it in 5 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Savant Capital held 32,957 shares of Astrana Health worth $1.53M as of Q2 2026.
  • Savant Capital bought 1,281 Astrana Health shares in Q2 2026, an estimated $46.1K.
  • Astrana Health made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #702 holding.
  • Savant Capital first reported a position in Astrana Health in Q2 2025 and has held it in 5 quarters since.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.